Well-known imported milk powder urgently recalled!

Abbott's global official website announced on February 17, U.

Enterobacter sakazakii is an opportunistic pathogen that exists in the environment and may pose a high health risk to infants aged 0-6 months, especially preterm infants, low birth weight infants and immunocompromised infants

In response to this matter, Abbott China said: Among the products voluntarily recalled this time, the Chinese market involves the infant nutritional supplement Xikang Baby Tim, which has been removed from the official Abbott flagship stores on Tmall and JD.

Enterobacter sakazakii (also known as Enterobacter sakazakii) is a species of Enterobacteriaceae, which was renamed Enterobacter sakazakii from Enterobacter cloacae in 1980

The Chinese market involves this product:

Hi Kang Baby Tim

According to reports, Abbott China stated that “except for the infant nutritional supplement Xikang Baby Tim, other nutritional products sold by Abbott China in the mainland are not affected

Abbott China further stated: "If consumers have products that are valid after April 1, 2022, they can send us a photo of the production date at the bottom of the product package through WeChat or email to confirm that it is the batch.

Abbott said: "There is no problem with products with an expiration date before April 1, 2022.

On Abbott China's official website, the "Professional Formula Series" product list contains an introduction to the infant nutritional supplement Similac Human Milk Fortifier.

The Abbott Special Formula Nutrition flagship store is also selling this product, priced at around 580 yuan per box

According to information from the State Administration for Market Regulation, Xikang Baby Tim has passed the registration of formula food for special medical purposes

Abbott's global sales increased by nearly 20% year-on-year

Abbott’s 2021 financial report released at the end of January this year showed that Abbott’s global sales in 2021 increased by 22.

In terms of business segments, in the fourth quarter of 2021, global sales of Abbott's nutritional products business were approximately US$2.

Among them, Quan'ansu, which provides comprehensive and balanced nutrition, and Yakult, which is tailored for diabetic patients, achieved remarkable sales results, helping the global sales of medical nutrition products to increase by 9% year-on-year

As shown in Abbott's financial report, in Abbott's nutrition business, medical nutrition is a very important performance growth engine